VentriPoint Diagnostics Ltd. develops advanced diagnostic solutions for cardiac assessment, utilizing its proprietary VMS+ technology. This system transforms 2D ultrasound scans into high-fidelity 3D models of the heart's four chambers, providing accurate volumetric measurements and ejection fractions comparable to MRI at a lower cost and time. VentriPoint's products are used in major hospitals across Europe, the U.K., the U.S., and Canada, targeting healthcare providers seeking efficient and precise cardiac diagnostics.
